RPL5 and colorectal cancer: The results indeed revealed that the CS&Z-induced inhibition of c-Myc was reversed following the loss of RPL5 (Figure 6), thereby tending to indicate that the CS&Z-regulated expression of c-Myc in colorectal cancer cells is mediated via RPL5.